Posted by Michael Wonder on 13 Jun 2018
Drug approved for leukaemia treatment
11 June 2018 - A drug that reduces the chances of relapse for people with an aggressive type of leukaemia is to be made available in Scotland.
Doctors can now prescribe midostaurin - brand name Rydapt - to treat patients with acute myeloid leukaemia.
About third of those with the condition have a cancer which carries a genetic mutation, giving them a poorer chance of survival.
